menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Hikma gets Health Canada approval for Kloxxado Nasal Spray 8 mg

    GLOBENEWSWIRE

    Enforcement Report - Week of March 12, 2025

    FDA

    Axsome Therapeutics Settles Sunosi Patent Litigation with Hikma

    GLOBENEWSWIRE

    Hikma & M42 sign strategic MoU to advance health innovation in UAE

    BIOSPECTRUM

    Hikma Pharma`s Generics Ertugliflozin Receives Approval in US

    FDA

    Enforcement Report - Week of January 15, 2025

    FDA

    Hikma & Emergent Partner For Kloxxado Sales In U.S. & Canada

    CONTRACTPHARMA

    Enforcement Report - Week of January 8, 2025

    FDA

    FDA approves Hikma`s generic of Novo`s diabetes drug Victoza

    REUTERS

    Hikma`s Generics Phytonadione Receives Approval in US

    FDA

    Hikma`s Generics Ephedrine Sulfate Receives Approval in US

    FDA

    Jazz, Hikma must face `reverse payment` claims over narcolepsy drug

    REUTERS

    Hikma Participates In Naloxone Training With Congressman

    PR NEWSWIRE

    KLOXXADO Naloxone Nasal Spray Shelf-Life Extended To 36 Months

    PR NEWSWIRE

    FDA Issues Form 483 to Hikma Injectables USA

    FDA

    Hikma Extends Pain Drug Recall Due To Potential Sedative Presence

    FIERCE PHARMA

    Hikma Pharmaceuticals Issues Voluntary Nationwide Recall for Acetaminophen Injection

    FDA

    FDA Issues Form 483 to Hikma Pharmaceuticals USA

    FDA

    After Stock crash and Staff cuts, Amarin wins bid to revive Vascepa patent

    FIERCE PHARMA

    Teva launches generic version of Novo Nordisk`s diabetes drug Victoza

    REUTERS

    Hikma Pharms Biologic Liraglutide Receives Tentative Approval in US

    FDA

    Enforcement Report - Week of May 29, 2024

    FDA

    Hikma`s Generic Edaravone Receives Approval in the U.S.

    FDA

    Collegium Authorized Generic Deal with Hikma for Nucynta®

    GLOBENEWSWIRE

    Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient

    FIERCE PHARMA

    Enforcement Report - Week of March 27, 2024

    FDA

    Hikma`s Generic Sodium Acetate Receives Approval in the U.S.

    FDA

    Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus

    PR NEWSWIRE

    Hikma`s Generic Levetiracetam Receives Approval in the U.S.

    FDA

    Hikma`s Generic Hydromorphone Hydrochloride Receives Approval in the U.S.

    FDA

    Hikma announces US launch of COMBOGESIC® IV

    PR NEWSWIRE

    Hikma to pay $115M in cash, $35M in donations to settle opioid claims

    ENDPTS

    Guardant Health and Hikma Partner to Offer Cancer Screening Tests

    BUSINESSWIRE

    Hikma marks two-year anniversary of KLOXXADO® launch

    PR NEWSWIRE

    Korea`s SK Biopharma enters MENA through strategic partnership with Hikma

    BIOSPECTRUM ASIA

    Rakuten Medical and Hikma Sign Licensing Agreement for Alluminox Platform

    PR NEWSWIRE

    Hikma Pharma Generic Dexamethasone Sodium Phosphate Receives Approval in the U.S.

    FDA

    Hikma Ventures invests in Octave Bioscience, a precision care platform

    PR NEWSWIRE

    Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory

    REUTERS

    Hikma exceeds 150 injectable medicines in US with launch of Dobutae Injection

    PR NEWSWIRE

    Enforcement Report - Week of May 24, 2023

    FDA

    Hikma Sees Signs Of A Bounceback For Generics

    PHARMAINTELIGENCE

    Hikma`s Generic Clindamycin Phosphate Receives Approval in the U.S.

    FDA

    Hikma`s Generic Gemcitabine Hydrochloride Receives Approval in the U.S.

    FDA

    Hikma accuses Amarin of suppressing generic versions of heart pill

    REUTERS

    Hikma`s Generic Regadenoson Receives Approval in the U.S.

    FDA

    Hikma`s Generic Betamethasone Acetate and Betamethasone Sodium Phosphate Receives Approval in the U.S.

    FDA

    Hikma`s Generic Morphine Sulfate Receives Approval in the U.S.

    FDA

    Hikma`s Generic Medroxyprogesterone Acetate Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of January 4, 2023

    FDA

    Hikma Pharma launches Xyrem’s generic in US

    EXPRESS PHARMA

    Hikma introduces generic Xyremin US market

    PHARMABIZ

    Hikma & Junshi Biosciences sign exclusive licensing agreementfor cancer treatment drug toripalimab

    PRESS RELEASE

    Junshi Biosciences & Hikma Sign Exclusive Licensing Agreement for Toripalimab

    GLOBENEWSWIRE

    Corcept Therapeutics Settles Patent Litigation with Hikma Pharmaceuticals

    GLOBENEWSWIRE

    Hikma`s Generic Fludrocortisone Acetate Receives Approval in the U.S.

    FDA

    Hikma, Teva, Sandoz Report Short Supply of Amoxicillin in US

    BLOOMBERG

    Hikma appoints Deneen Vojta as a Director

    PRESS RELEASE

    Hikma`s Generic Methylprednisolone Sodium Succinate Receives Approval in the U.S.

    FDA

    Glenmark`s partner Hikma launches specialty drug Ryaltris in US

    ECONOMICTIMES

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.